PURPOSE: To identify the genetic cause of isolated canine ectopia lentis, a well-characterized veterinary disease commonly referred to as primary lens luxation (PLL) and to compare the canine disease with a newly described human Weill-Marchesani syndrome (WMS)-like disease of similar genetic etiology. METHODS: Genomewide association analysis and fine mapping by homozygosity were used to identify the chromosomal segment harboring the PLL locus. The resequencing of a regional candidate gene was used to discover a mutation in a splice donor site predicted to cause exon skipping. Exon skipping was confirmed by reverse transcription-polymerase chain reaction amplification of RNA isolated from PLL-affected eyes and from skin fibroblast cultures from PLL-affected dogs. An allelic discrimination assay was used to genotype individual dogs at the splice donor site mutation. RESULTS: The PLL locus was mapped to a 664-kb region of canine chromosome 3 containing regional candidate gene ADAMTS17. Resequencing ADAMTS17 revealed a GT-->AT splice-donor-site mutation at the 5' end of intron 10. The predicted exon 10 skipping and resultant frame shift were confirmed with RNA derived from PLL-affected dogs. The ADAMTS17 mutation was significantly associated with clinical PLL in three different dog breeds. CONCLUSIONS: A truncating mutation in canine ADAMTS17 causes PLL, a well-characterized veterinary disease, which can now be compared to a recently described rare WMS-like disease caused by truncating mutations of the human ADAMTS17 ortholog.
PURPOSE: To identify the genetic cause of isolated canineectopia lentis, a well-characterized veterinary disease commonly referred to as primary lens luxation (PLL) and to compare the canine disease with a newly described humanWeill-Marchesani syndrome (WMS)-like disease of similar genetic etiology. METHODS: Genomewide association analysis and fine mapping by homozygosity were used to identify the chromosomal segment harboring the PLL locus. The resequencing of a regional candidate gene was used to discover a mutation in a splice donor site predicted to cause exon skipping. Exon skipping was confirmed by reverse transcription-polymerase chain reaction amplification of RNA isolated from PLL-affected eyes and from skin fibroblast cultures from PLL-affected dogs. An allelic discrimination assay was used to genotype individual dogs at the splice donor site mutation. RESULTS: The PLL locus was mapped to a 664-kb region of canine chromosome 3 containing regional candidate gene ADAMTS17. Resequencing ADAMTS17 revealed a GT-->AT splice-donor-site mutation at the 5' end of intron 10. The predicted exon 10 skipping and resultant frame shift were confirmed with RNA derived from PLL-affected dogs. The ADAMTS17 mutation was significantly associated with clinical PLL in three different dog breeds. CONCLUSIONS: A truncating mutation in canineADAMTS17 causes PLL, a well-characterized veterinary disease, which can now be compared to a recently described rare WMS-like disease caused by truncating mutations of the humanADAMTS17 ortholog.
Authors: Natalie A Villani; Garrett Bullock; Jennifer R Michaels; Osamu Yamato; Dennis P O'Brien; Tendai Mhlanga-Mutangadura; Gary S Johnson; Martin L Katz Journal: Mol Genet Metab Date: 2019-04-17 Impact factor: 4.797
Authors: Wendy E Kutz; Lauren W Wang; Hannah L Bader; Alana K Majors; Kazushi Iwata; Elias I Traboulsi; Lynn Y Sakai; Douglas R Keene; Suneel S Apte Journal: J Biol Chem Date: 2011-03-14 Impact factor: 5.157
Authors: Barbara C Hoopes; Maud Rimbault; David Liebers; Elaine A Ostrander; Nathan B Sutter Journal: Mamm Genome Date: 2012-08-18 Impact factor: 2.957
Authors: Fabiana H G Farias; Rong Zeng; Gary S Johnson; G D Shelton; Dominique Paquette; Dennis P O'Brien Journal: BMC Vet Res Date: 2012-07-26 Impact factor: 2.741
Authors: Franz P W Radner; Slaheddine Marrakchi; Peter Kirchmeier; Gwang-Jin Kim; Florence Ribierre; Bourane Kamoun; Leila Abid; Michael Leipoldt; Hamida Turki; Werner Schempp; Roland Heilig; Mark Lathrop; Judith Fischer Journal: PLoS Genet Date: 2013-06-06 Impact factor: 5.917
Authors: Connie Y Yeh; Orly Goldstein; Anna V Kukekova; Debbie Holley; Amy M Knollinger; Heather J Huson; Susan E Pearce-Kelling; Gregory M Acland; András M Komáromy Journal: BMC Genet Date: 2013-04-20 Impact factor: 2.797